The following is a summary of "Real-world comparison of T2-biologics effectiveness in severe allergic asthma with nasal ...

A decision to proceed with nasal polyp surgery was recorded in just 0.5% of tezepelumab-treated patients compared to 22.1% in the placebo group (hazard ratio, 0.02). Systemic glucocorticoid use ...

Among patients with previous sinus surgery for chronic rhinosinusitis with nasal polyps, the number of past surgeries did not ...

Patients with chronic rhinosinusitis with nasal polyps saw improvements across all endpoints with tezepelumab, according to an abstract presented here. Results were seen as early as 2 and 4 weeks, ...

Recent studies examine the burden of CRSwNP, looking at quality of life in patients and caregivers and assessing how CRSwNP ...

Neffy (epinephrine nasal spray) 1mg is approved for the emergency treatment of type 1 allergic reactions, including ...

The trial showed that treatment with the therapy decreased the severity of nasal polyps and congestion at week 52, as well as the need for surgery and the use of systemic corticosteroid.

Tezspire lowered the need for nasal polyp surgery by 98% and systemic corticosteroid use by 88% compared to placebo in CRSwNP patients. Feel unsure about the market’s next move? Copy trade ...